Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Universal Genetic Testing for Cancer Risk Reduction

NYU Langone Health · NCT06926816

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 25–39 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
600
US sites recruiting
1
Study start
March 4, 2025
Record last updated
March 2, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this research study is to see if offering genetic testing for cancer-related genes is feasible and acceptable for patients presenting for gynecology clinic visits, instead of needing to see specialized providers or needing to meet specific criteria. The primary aim to assess the proportion of patients who undergo genetic testing, and the proportion of patients with pathogenic variants.

Being studied: Natera® Empower™ hereditary cancer panel test; Specialist Referral

Conditions: Genetic Testing

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Female patients between ages of 25-39 years at the time of visit
  • Receive gynecologic care at an affiliated NYU Langone Health (NYULH) site listed in this protocol.

Exclusion Criteria

  • Personal history of ovarian, fallopian tube, primary peritoneal, or uterine cancers
  • Previously undergone germline testing for ovarian cancer risk variants (prior commercial saliva-based kits, such as 23andMe, are acceptable)
  • History of bilateral salpingo-oophorectomy
  • Visit related to pregnancy or immediately postpartum (within 2 weeks)

Recruiting US locations

Study contacts (from the official record)

  • Bhavana Pothuri, MD, MS · 212-731-6455 · Bhanava.pothuri@nyulangone.org
  • Sarah Lee · 646-501-7876 · Sarah.lee@nyulangone.org
Universal Genetic Testing for Cancer Risk Reduction (NCT06926816) | Bored Studies